Under Armour shares shot up 20% on Thursday as the sportswear maker raised its annual profit forecast, betting on lower input ...

Under Armour's long-awaited move into a new global headquarters in South Baltimore will begin next week, President and CEO ...

Balenciaga’s new tie-up with Under Armour is here. According to the luxury fashion house, the new collaborative range ...

Additionally, Under Armour’s leadership team appears to be more empowered, fostering a culture of patience and strategic investment. The company’s approach to elevating its product offerings and ...

Under Armour (UA, UAA) is rallying in Thursday’s premarket as the company was able to maintain profitability despite an 11% drop in revenue and softer sales across most segments, resulting in ...

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following ...

CEO and founder Kevin Plank returned to lead the company in April. The post Under Armour Turnaround Underway, Raises Profit Guidance appeared first on Front Office Sports.

Even better, Jefferson used the national spotlight to debut a luxurious pair of custom Under Armour football cleats. Under Armour created a special player-exclusive "Chrome 18" colorway for Jefferson.

B.A.S.S. announced today that outdoor apparel, footwear and accessories manufacturer Under Armour, Inc. will be the presenting sponsor of the 2025 Bassmaster Classic in Fort Worth, Texas. “We are ...

Armour Thyroid (desiccated thyroid) is a brand-name oral tablet prescribed for certain thyroid conditions. As with other drugs, Armour Thyroid can cause side effects, such as temporary hair loss ...

Get big savings by browsing new arrivals and best-sellers with Under Armour promo codes plus get FREE SHIPPING and FREE Returns. You will never miss out on another sale when you shop with the help ...

Armour Residential REIT (ARR) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $1.08 per share a year ago.